BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 29900673)

  • 1. Dynamics of virus-specific T cell immunity in pediatric liver transplant recipients.
    Arasaratnam RJ; Tzannou I; Gray T; Aguayo-Hiraldo PI; Kuvalekar M; Naik S; Gaikwad A; Liu H; Miloh T; Vera JF; Himes RW; Munoz FM; Leen AM
    Am J Transplant; 2018 Sep; 18(9):2238-2249. PubMed ID: 29900673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Posttransplant biopsy risk for stable long-term pediatric liver transplant recipients: 451 percutaneous biopsies from two multicenter immunosuppression withdrawal trials.
    Perito ER; Martinez M; Turmelle YP; Mason K; Spain KM; Bucuvalas JC; Feng S
    Am J Transplant; 2019 May; 19(5):1545-1551. PubMed ID: 30614623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative EBV viral loads and immunosuppression alterations can decrease PTLD incidence in pediatric liver transplant recipients.
    Lee TC; Savoldo B; Rooney CM; Heslop HE; Gee AP; Caldwell Y; Barshes NR; Scott JD; Bristow LJ; O'Mahony CA; Goss JA
    Am J Transplant; 2005 Sep; 5(9):2222-8. PubMed ID: 16095501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of immunosuppression minimization and withdrawal early after liver transplantation.
    Shaked A; DesMarais MR; Kopetskie H; Feng S; Punch JD; Levitsky J; Reyes J; Klintmalm GB; Demetris AJ; Burrell BE; Priore A; Bridges ND; Sayre PH
    Am J Transplant; 2019 May; 19(5):1397-1409. PubMed ID: 30506630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of donor viral replication at transplant on recipient infections posttransplant: a prospective study.
    Verghese PS; Schmeling DO; Knight JA; Matas AJ; Balfour HH
    Transplantation; 2015 Mar; 99(3):602-8. PubMed ID: 25148381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful Treatment of Kaposi Sarcoma-Associated Herpesvirus Inflammatory Cytokine Syndrome After Kidney-Liver Transplant: Correlations With the Human Herpesvirus 8 miRNome and Specific T Cell Response.
    Mularoni A; Gallo A; Riva G; Barozzi P; Miele M; Cardinale G; Vizzini G; Volpes R; Grossi P; Di Carlo D; Luca A; Trenti T; Luppi M; Conaldi PG
    Am J Transplant; 2017 Nov; 17(11):2963-2969. PubMed ID: 28489271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viral load, CMV-specific T-cell immune response and cytomegalovirus disease in solid organ transplant recipients at higher risk for cytomegalovirus infection during preemptive therapy.
    Martín-Gandul C; Pérez-Romero P; Blanco-Lobo P; Benmarzouk-Hidalgo OJ; Sánchez M; Gentil MA; Bernal C; Sobrino JM; Rodríguez-Hernández MJ; Cordero E;
    Transpl Int; 2014 Oct; 27(10):1060-8. PubMed ID: 24964364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship Among Viremia/Viral Infection, Alloimmunity, and Nutritional Parameters in the First Year After Pediatric Kidney Transplantation.
    Ettenger R; Chin H; Kesler K; Bridges N; Grimm P; Reed EF; Sarwal M; Sibley R; Tsai E; Warshaw B; Kirk AD
    Am J Transplant; 2017 Jun; 17(6):1549-1562. PubMed ID: 27989013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of quantitative Epstein-Barr virus polymerase chain reaction and preemptive immunosuppression reduction in pediatric liver transplantation: a preliminary experience.
    Kogan-Liberman D; Burroughs M; Emre S; Moscona A; Shneider BL
    J Pediatr Gastroenterol Nutr; 2001 Oct; 33(4):445-9. PubMed ID: 11698761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCL8 and the Immune Control of Cytomegalovirus in Organ Transplant Recipients.
    Lisboa LF; Egli A; Fairbanks J; O'Shea D; Manuel O; Husain S; Kumar D; Humar A
    Am J Transplant; 2015 Jul; 15(7):1882-92. PubMed ID: 25764912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal dose and type of immunosuppression in a national cohort of Australian liver, heart, and lung transplant recipients, 1984-2006.
    Na R; Laaksonen MA; Grulich AE; Webster AC; Meagher NS; McCaughan GW; Keogh AM; Vajdic CM
    Clin Transplant; 2015 Nov; 29(11):978-90. PubMed ID: 26278925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose immunosuppression reduces the incidence of post-transplant lymphoproliferative disease in pediatric liver graft recipients.
    Ganschow R; Schulz T; Meyer T; Broering DC; Burdelski M
    J Pediatr Gastroenterol Nutr; 2004 Feb; 38(2):198-203. PubMed ID: 14734884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of Antithymocyte Globulin Treatment for Severe Centrilobular Injury Following Pediatric Liver Transplant: Clinical Significance of Monitoring Lymphocyte Subset.
    Uchida H; Sakamoto S; Shimizu S; Takeda M; Yanagi Y; Fukuda A; Uchiyama T; Irie R; Kasahara M
    Exp Clin Transplant; 2020 Jun; 18(3):325-333. PubMed ID: 32281527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Monitoring of cytomegalovirus-specific CD4+ and CD8+ T cell responses by cytokine flow cytometry in renal transplant recipients].
    Kılınçkaya Doğan H; Mutlu E; Köksoy S; Yılmaz VT; Koçak H; Çolak D; Mutlu D; Günseren F; Dinçkan A; Aliosmanoğlu İ; Süleymanlar G; Gültekin M
    Mikrobiyol Bul; 2016 Apr; 50(2):224-35. PubMed ID: 27175495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune-mediated graft dysfunction in liver transplant recipients with hepatitis C virus treated with direct-acting antiviral therapy.
    Chan C; Schiano T; Agudelo E; Paul Haydek J; Hoteit M; Laurito MP; Norvell JP; Terrault N; Verna EC; Yang A; Levitsky J
    Am J Transplant; 2018 Oct; 18(10):2506-2512. PubMed ID: 30075485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective Analyses of Circulating B Cell Subsets in ABO-Compatible and ABO-Incompatible Kidney Transplant Recipients.
    Schlößer HA; Thelen M; Dieplinger G; von Bergwelt-Baildon A; Garcia-Marquez M; Reuter S; Shimabukuro-Vornhagen A; Wennhold K; Haustein N; Buchner D; Heiermann N; Kleinert R; Wahba R; Ditt V; Kurschat C; Cingöz T; Becker J; Stippel DL; von Bergwelt-Baildon M
    Am J Transplant; 2017 Feb; 17(2):542-550. PubMed ID: 27529836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and virologic outcomes in high-risk adult Epstein-Barr virus mismatched organ transplant recipients.
    Kumar D; Patil N; Husain S; Chaparro C; Bhat M; Kim SJ; Humar A
    Clin Transplant; 2017 Jul; 31(7):. PubMed ID: 28489256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Herpesviruses excretion in saliva of pediatric transplant recipients.
    Correa Sierra CB; Kourí Cardellá V; Pérez Santos L; Silverio CE; Hondal N; Florin J
    Transpl Infect Dis; 2017 Dec; 19(6):. PubMed ID: 28834054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective, comprehensive, and effective viral monitoring in children undergoing allogeneic hematopoietic stem cell transplantation.
    Schönberger S; Meisel R; Adams O; Pufal Y; Laws HJ; Enczmann J; Dilloo D
    Biol Blood Marrow Transplant; 2010 Oct; 16(10):1428-35. PubMed ID: 20399877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of early EBV and/or CMV viremia on graft function and acute cellular rejection in pediatric liver transplantation.
    Indolfi G; Heaton N; Smith M; Mieli-Vergani G; Zuckerman M
    Clin Transplant; 2012; 26(1):E55-61. PubMed ID: 21981027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.